Karluss Thomas

4.2k total citations · 1 hit paper
20 papers, 2.8k citations indexed

About

Karluss Thomas is a scholar working on Immunology and Allergy, Health, Toxicology and Mutagenesis and Materials Chemistry. According to data from OpenAlex, Karluss Thomas has authored 20 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology and Allergy, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Materials Chemistry. Recurrent topics in Karluss Thomas's work include Food Allergy and Anaphylaxis Research (6 papers), Nanoparticles: synthesis and applications (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Karluss Thomas is often cited by papers focused on Food Allergy and Anaphylaxis Research (6 papers), Nanoparticles: synthesis and applications (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Karluss Thomas collaborates with scholars based in United States, Germany and France. Karluss Thomas's co-authors include Harry M. Olson, A. M. Monro, Graham R. Betton, William M. Bracken, Allen H. Heller, Peter J. Smith, Bruce M. Berger, Michael A. Dorato, Patrick D. Lilly and Gerald J. Kolaja and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, British Journal of Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Karluss Thomas

20 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals

2000 1.4k citations Harry M. Olson, Graham R. Betton et al. Regulatory Toxicology and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karluss Thomas United States	16	651	529	501	444	293	20	2.8k
Eric Fabian Germany	27	464 0.7×	638 1.2×	262 0.5×	293 0.7×	228 0.8×	88	2.6k
Bennard van Ravenzwaay Germany	35	925 1.4×	1.1k 2.1×	505 1.0×	265 0.6×	401 1.4×	175	4.4k
Shayne C. Gad United States	27	183 0.3×	535 1.0×	364 0.7×	127 0.3×	219 0.7×	128	2.8k
B. van Ravenzwaay Germany	25	631 1.0×	411 0.8×	263 0.5×	96 0.2×	183 0.6×	55	2.2k
Darrell R. Boverhof United States	23	467 0.7×	443 0.8×	231 0.5×	110 0.2×	75 0.3×	40	2.1k
R.A. Woutersen Netherlands	36	152 0.2×	910 1.7×	381 0.8×	151 0.3×	208 0.7×	141	4.0k
Nakissa Sadrieh United States	28	791 1.2×	685 1.3×	518 1.0×	166 0.4×	108 0.4×	62	2.9k
Albert Braeuning Germany	38	723 1.1×	1.9k 3.5×	626 1.2×	717 1.6×	399 1.4×	240	5.8k
Nan Mei United States	35	453 0.7×	1.4k 2.7×	445 0.9×	581 1.3×	639 2.2×	143	4.0k
Raymond Pieters Netherlands	37	168 0.3×	605 1.1×	150 0.3×	118 0.3×	212 0.7×	176	4.3k

Countries citing papers authored by Karluss Thomas

Since Specialization

Citations

This map shows the geographic impact of Karluss Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karluss Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karluss Thomas more than expected).

Fields of papers citing papers by Karluss Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karluss Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karluss Thomas. The network helps show where Karluss Thomas may publish in the future.

Co-authorship network of co-authors of Karluss Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Karluss Thomas. A scholar is included among the top collaborators of Karluss Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karluss Thomas. Karluss Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Treye, Tina Bahadori, Nora Savage, & Karluss Thomas. (2009). Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 1(4). 426–433. 26 indexed citations

Thomas, Karluss, Gary A. Bannon, Corinne Hérouet-Guicheney, et al.. (2009). Scientific advancement of novel protein allergenicity evaluation: An overview of work from the HESI Protein Allergenicity Technical Committee (2000–2008). Food and Chemical Toxicology. 47(6). 1041–1050. 23 indexed citations

Thomas, Karluss, Corinne Hérouet-Guicheney, Gregory S. Ladics, et al.. (2008). Current and future methods for evaluating the allergenic potential of proteins: International workshop report 23–25 October 2007. Food and Chemical Toxicology. 46(9). 3219–3225. 21 indexed citations

Darpö, Börje, et al.. (2008). Moving towards better predictors of drug‐induced torsades de pointes. British Journal of Pharmacology. 154(7). 1550–1553. 14 indexed citations

Thomas, Karluss, Corinne Hérouet-Guicheney, Gregory S. Ladics, et al.. (2007). Evaluating the effect of food processing on the potential human allergenicity of novel proteins: International workshop report. Food and Chemical Toxicology. 45(7). 1116–1122. 151 indexed citations

Thomas, Karluss, Gary A. Bannon, Corinne Hérouet-Guicheney, et al.. (2007). The Utility of an International Sera Bank for Use in Evaluating the Potential Human Allergenicity of Novel Proteins. Toxicological Sciences. 97(1). 27–31. 12 indexed citations

Chiang, Alan Y., et al.. (2007). ILSI–HESI cardiovascular safety subcommittee dataset: An analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc). Journal of Pharmacological and Toxicological Methods. 56(2). 95–102. 20 indexed citations

Nichols, John W., Susan Erhardt, Scott D. Dyer, et al.. (2007). Use ofIn VitroAbsorption, Distribution, Metabolism, and Excretion (ADME) Data in Bioaccumulation Assessments for Fish. Human and Ecological Risk Assessment An International Journal. 13(6). 1164–1191. 41 indexed citations

Nichols, John W., Susan Erhardt, Scott D. Dyer, et al.. (2007). WORKSHOP REPORT Use of In Vitro Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Bioaccumulation Assessments for Fish. 6 indexed citations

10.

Borm, Paul J. A., Frederick C. Klaessig, Timothy D. Landry, et al.. (2006). Research Strategies for Safety Evaluation of Nanomaterials, Part V: Role of Dissolution in Biological Fate and Effects of Nanoscale Particles. Toxicological Sciences. 90(1). 23–32. 426 indexed citations

11.

Dressler, William E., Henry F. Edelhauser, Francis H. Kruszewski, et al.. (2006). Proposed new classification scheme for chemical injury to the human eye. Regulatory Toxicology and Pharmacology. 45(2). 206–213. 23 indexed citations

12.

Bass, Alan, et al.. (2006). ILSI-HESI cardiovascular safety subcommittee initiative: Evaluation of three non-clinical models of QT prolongation. Journal of Pharmacological and Toxicological Methods. 54(2). 116–129. 87 indexed citations

13.

Thomas, Karluss, et al.. (2006). Research Strategies for Safety Evaluation of Nanomaterials, Part VIII: International Efforts to Develop Risk-Based Safety Evaluations for Nanomaterials. Toxicological Sciences. 92(1). 23–32. 40 indexed citations

14.

Thomas, Treye, et al.. (2006). Research Strategies for Safety Evaluation of Nanomaterials, Part VII: Evaluating Consumer Exposure to Nanoscale Materials. Toxicological Sciences. 91(1). 14–19. 85 indexed citations

15.

Thomas, Karluss, Corinne Hérouet, Gary A. Bannon, et al.. (2005). Evaluation of IP mouse models for assessing the allergenic potential of proteins. Journal of Allergy and Clinical Immunology. 115(2). S250–S250. 6 indexed citations

16.

Thomas, Karluss & Philip Sayre. (2005). Research Strategies for Safety Evaluation of Nanomaterials, Part I: Evaluating the Human Health Implications of Exposure to Nanoscale Materials. Toxicological Sciences. 87(2). 316–321. 132 indexed citations

17.

Thomas, Karluss, Gary A. Bannon, Susan L. Hefle, et al.. (2005). In Silico Methods for Evaluating Human Allergenicity to Novel Proteins: International Bioinformatics Workshop Meeting Report, 23–24 February 2005. Toxicological Sciences. 88(2). 307–310. 30 indexed citations

18.

Judson, Philip N., Paul Cooke, Nancy G. Doerrer, et al.. (2005). Towards the creation of an international toxicology information centre. Toxicology. 213(1-2). 117–128. 37 indexed citations

19.

Holsapple, Michael P., William H. Farland, Timothy D. Landry, et al.. (2005). Research Strategies for Safety Evaluation of Nanomaterials, Part II: Toxicological and Safety Evaluation of Nanomaterials, Current Challenges and Data Needs. Toxicological Sciences. 88(1). 12–17. 178 indexed citations

20.

Olson, Harry M., Graham R. Betton, Denise E. Robinson, et al.. (2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology. 32(1). 56–67. 1417 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact